Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: A nationwide population study

British Journal of Dermatology

Volumn 165, Issue 6, 2011, Pages 1273-1279

  Kuo, C F ^a,c   See, L C ^a,b   Yu, K H ^b,c   Chou, I J ^d   Chang, H C ^c   Chiou, M J ^a   Luo, S F ^b,c  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER RISK; CRITICAL ILLNESS; DERMATOMYOSITIS; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NASOPHARYNX CANCER; POLYMYOSITIS; POPULATION RESEARCH; PRIORITY JOURNAL; REGISTER; STANDARDIZATION; TAIWAN;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DERMATOMYOSITIS; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; MIDDLE AGED; NEOPLASMS; POLYMYOSITIS; REGISTRIES; RISK FACTORS; TAIWAN; YOUNG ADULT;

EID: 82255175481     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10595.x     Document Type: Article

References (39)

1. Mastaglia FL, Phillips BA,. Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria. Rheum Dis Clin North Am 2002; 28: 723-41. (Pubitemid 36008549)
2. Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev 2010; 9: 449-53.
3. Chen IJ, Jan Wu YJ, Lin CW, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 2009; 28: 639-46.
4. Lynn SJ, Sawyers SM, Moller PW, et al. Adult-onset inflammatory myopathy: North Canterbury experience 1989-2001. Intern Med J 2005; 35: 170-3. (Pubitemid 40389014)
5. Weitoft T,. Occurrence of polymyositis in the county of Gavleborg, Sweden. Scand J Rheumatol 1997; 26: 104-6.
6. Lu TH, Shau WY, Shih TP, et al. Factors associated with errors in death certificate completion. A national study in Taiwan. J Clin Epidemiol 2001; 54: 232-8.
7. Lu TH, Lee MC, Chou MC,. Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics. Int J Epidemiol 2000; 29: 336-43.
8. Ulm K,. A simple method to calculate the confidence interval of a standardized mortality ratio (SMR). Am J Epidemiol 1990; 131: 373-5. (Pubitemid 20118904)
9. Kurland LT, Hauser WA, Ferguson RH, et al. Epidemiologic features of diffuse connective tissue disorders in Rochester, Minn., 1951 through 1967, with special reference to systemic lupus erythematosus. Mayo Clin Proc 1969; 44: 649-63.
10. Benbassat J, Geffel D, Zlotnick A,. Epidemiology of polymyositis- dermatomyositis in Israel, 1960-76. Isr J Med Sci 1980; 16: 197-200. (Pubitemid 10094637)
11. Medsger TA Jr, Dawson WN Jr, Masi AT,. The epidemiology of polymyositis. Am J Med 1970; 48: 715-23.
12. Patrick M, Buchbinder R, Jolley D, et al. Incidence of inflammatory myopathies in Victoria, Australia, and evidence of spatial clustering. J Rheumatol 1999; 26: 1094-100. (Pubitemid 29215074)
13. Bernatsky S, Joseph L, Pineau CA, et al. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2009; 68: 1192-6.
14. Hanissian AS, Masi AT, Pitner SE, et al. Polymyositis and dermatomyositis in children: an epidemiologic and clinical comparative analysis. J Rheumatol 1982; 9: 390-4. (Pubitemid 13229491)
15. Denardo BA, Tucker LB, Miller LC, et al. Demography of a regional pediatric rheumatology patient population. Affiliated Children's Arthritis Centers of New England. J Rheumatol 1994; 21: 1553-61. (Pubitemid 24261546)
16. Pelkonen PM, Jalanko HJ, Lantto RK, et al. Incidence of systemic connective tissue diseases in children: a nationwide prospective study in Finland. J Rheumatol 1994; 21: 2143-6. (Pubitemid 24352367)
17. Mendez EP, Lipton R, Ramsey-Goldman R, et al. US incidence of juvenile dermatomyositis, 1995-1998: results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases Registry. Arthritis Rheum 2003; 49: 300-5. (Pubitemid 36682395)
18. Symmons DP, Sills JA, Davis SM,. The incidence of juvenile dermatomyositis: results from a nation-wide study. Br J Rheumatol 1995; 34: 732-6.
19. Oddis CV, Conte CG, Steen VD, et al. Incidence of polymyositis- dermatomyositis: a 20-year study of hospital diagnosed cases in Allegheny County, PA 1963-1982. J Rheumatol 1990; 17: 1329-34. (Pubitemid 20382859)
20. Wilson FC, Ytterberg SR, St Sauver JL, et al. Epidemiology of sporadic inclusion body myositis and polymyositis in Olmsted County, Minnesota. J Rheumatol 2008; 35: 445-7. (Pubitemid 351374418)
21. Kusumi M, Nakashima K, Nakayama H, et al. Epidemiology of inflammatory neurological and inflammatory neuromuscular diseases in Tottori Prefecture, Japan. Psychiatry Clin Neurosci 1995; 49: 169-74.
22. Pearson CM, Bohan A,. The spectrum of polymyositis and dermatomyositis. Med Clin North Am 1977; 61: 439-57. (Pubitemid 8154305)
23. Arnett FC, Targoff IN, Mimori T, et al. Interrelationship of major histocompatibility complex class II alleles and autoantibodies in four ethnic groups with various forms of myositis. Arthritis Rheum 1996; 39: 1507-18. (Pubitemid 26314984)
24. Hill CL, Zhang Y, Sigurgeirsson B, et al. Frequency of specific cancer types in dermatomyositis and polymyositis: a population-based study. Lancet 2001; 357: 96-100. (Pubitemid 32094911)
25. Stockton D, Doherty VR, Brewster DH,. Risk of cancer in patients with dermatomyositis or polymyositis, and follow-up implications: a Scottish population-based cohort study. Br J Cancer 2001; 85: 41-5. (Pubitemid 32695714)
26. Sigurgeirsson B, Lindelof B, Edhag O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. A population-based study. N Engl J Med 1992; 326: 363-7.
27. Buchbinder R, Forbes A, Hall S, et al. Incidence of malignant disease in biopsy-proven inflammatory myopathy. A population-based cohort study. Ann Intern Med 2001; 134: 1087-95.
28. Wakata N, Kurihara T, Saito E, et al. Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study. Int J Dermatol 2002; 41: 729-34. (Pubitemid 35422835)
29. Fardet L, Dupuy A, Gain M, et al. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis. Medicine (Baltimore) 2009; 88: 91-7.
30. Hu WJ, Chen DL, Min HQ,. Study of 45 cases of nasopharyngeal carcinoma with dermatomyositis. Am J Clin Oncol 1996; 19: 35-8.
31. Fung WK, Chan HL, Lam WM,. Amyopathic dermatomyositis in Hong Kong-association with nasopharyngeal carcinoma. Int J Dermatol 1998; 37: 659-63. (Pubitemid 28428314)
32. Wong KO,. Dermatomyositis: a clinical investigation of twenty-three cases in Hong Kong. Br J Dermatol 1969; 81: 544-7.
33. Chan HL,. Dermatomyositis and cancer in Singapore. Int J Dermatol 1985; 24: 447-50. (Pubitemid 15246722)
34. Lin JC, Wang WY, Chen KY, et al. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med 2004; 350: 2461-70. (Pubitemid 38736543)
35. Jeng KC, Hsu CY, Liu MT, et al. Prevalence of Taiwan variant of Epstein-Barr virus in throat washings from patients with head and neck tumors in Taiwan. J Clin Microbiol 1994; 32: 28-31.
36. Ferris RL, Koch WM,. Connective tissue disease coincident with nasopharyngeal carcinoma: two sporadic cases in a Western population. Arch Otolaryngol Head Neck Surg 2003; 129: 101-5. (Pubitemid 36070884)
37. Andras C, Ponyi A, Constantin T, et al. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study. J Rheumatol 2008; 35: 438-44. (Pubitemid 351374417)
38. Lundberg IE, Forbess CJ,. Mortality in idiopathic inflammatory myopathies. Clin Exp Rheumatol 2008; 26 (5 Suppl. 51): S109-14.
39. Airio A, Kautiainen H, Hakala M,. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol 2006; 25: 234-9. (Pubitemid 43372323)